Related Experiment Video
Updated: May 11, 2025

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
Assessing the Impact of Multiple Imputation Algorithms on Pharmacokinetic Model Performance: A Simulation-Based Study
Thomas Duflot1,2, Lucie Fayette3, Céline Konecki4
1Department of Pharmacology, University of Reims Champagne-Ardenne, Reims University Hospital, PPF UR 3801, Reims, France. thomas.duflot@chu-rouen.fr.
None:
This study compared multiple imputation (MI) algorithms in a one-compartment pharmacokinetic (PK) scenario with oral absorption. Four covariates (two continuous, two dichotomous) linked to PK parameters were randomly removed under a missing completely at random (MCAR) mechanism. The aim was to identify which algorithm best preserves covariate distributions and PK parameter estimates. The original dataset included 100 individuals, each with five sampling occasions. Missing data were introduced at 5%, 20%, 50%, and 75% for the four covariates under the MCAR assumption. Five MI algorithms (Mice, Amelia, missForest, rMIDAS, XGBoost) were tested. Absolute and relative errors and concordance metrics were used to assess performance. Population and individual parameter estimates were compared across imputed and original datasets using Monolix2024R1®. MissForest (MF) and Amelia yielded lower errors for continuous covariates whereas dichotomous variables were poorly imputed. Based on objective function values, Mice perform best at 5% and MF at 20% of missingness. Increasing missingness decreased covariate effects and increased the estimated inter-individual variances. Individual parameter estimation accurately captured individual-level variability across all imputed datasets. MI methods appear effective for covariate imputation in PK modeling, offering reliable results up to 20% missingness under an MCAR mechanism. Future research should explore refined strategies, including advanced modeling frameworks and Bayesian approaches for imputation. Enhancing our understanding of missing data processes will be crucial for robust PK analyses across diverse clinical settings.
More Related Videos
09:35A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
Published on: August 16, 2017
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
Related Concept Videos
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Analysis of Population Pharmacokinetic Data
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Mechanistic Models: Overview of Compartment Models